Modern treatment of vulvar cancer
Radiology and Oncology, 2020 Vulvar cancer accounts for 3–5% of malignant diseases of the female genital tract. The Slovenian incidence rate is 5.5/100,000, which means 57 new cases per year. The most common histological type (90%) is squamous cell carcinoma.
Merlo Sebastjan
doaj +6 more sources
Prognostic Factors for Vulvar Cancer
Acta Clinica Croatica, 2021 The aim of this retrospective study was to show the effect of clinical, pathologic, cytologic and therapeutic prognostic factors on treatment outcome and survival of patients suffering from vulvar cancer and to determine prognostic significance of each
Ivana Miljanović-Špika +4 more
doaj +3 more sources
Factors associated with vulvar cancer from 2005 to 2021 in Togo, sub-Saharan Africa [PDF]
BMC Women's Health, 2023 Background vulvar cancer, once predominantly diagnosed in older women, is increasingly being diagnosed in younger individuals, due to Human Papillomavirus (HPV) infection.
Tchin Darré +13 more
doaj +2 more sources
Epidemiology of vulvar cancer in Croatia. [PDF]
Croat Med J, 2023 To assess the incidence and mortality trends of invasive vulvar cancer in Croatia between 2001 and 2019/2020.The incidence data for the period 2001-2019 were obtained from the Croatian National Cancer Registry. The number of deaths from invasive vulvar cancer by age groups between 2001 and 2020 was obtained from the Croatian Bureau of Statistics ...
Barišić I +3 more
europepmc +3 more sources
Incidence Trends of Vulvar Cancer in the United States: A 20‐Year Population‐Based Study [PDF]
Cancer ReportsBackground Despite being uncommon, vulvar cancer is a serious health concern with a 5‐year relative survival rate of 71%. Aims The objective was to investigate the incidence rates of this disease across different racial, ethnic, and histological ...
Seyed Ehsan Mousavi +4 more
doaj +2 more sources
Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report [PDF]
Gynecologic Oncology ReportsThere is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer +6 more
doaj +2 more sources
Treatment of vulvar cancer recurrence with electrochemotherapy: a case-control study [PDF]
Acta OncologicaBackground: Electrochemotherapy (ECT) is a combined treatment method based on electroporation and simultaneous chemotherapy. In cases where radiotherapy has previously been used, surgery is often the only treatment option for vulvar cancer recurrence ...
Gregor Vivod +7 more
doaj +2 more sources
Anxiety and depression among women with newly diagnosed vulvar cancer – A nationwide longitudinal study [PDF]
Acta Obstetricia et Gynecologica ScandinavicaIntroduction Our objective was to investigate the trajectories of anxiety, depression, emotional and social functioning in women with newly diagnosed vulvar cancer from the time of diagnosis to 12 months after treatment.
Diana Zach +7 more
doaj +2 more sources
Vulvar cancer incidence and net survival in Sweden 1960 to 2019: A population‐based national study [PDF]
Acta Obstetricia et Gynecologica ScandinavicaIntroduction Vulvar cancer is a rare gynecological cancer affecting mostly older women. The aim of this population‐based study was to investigate the incidence and net survival of vulvar cancer in Swedish women from 1960 to 2019.
Louise Moberg +4 more
doaj +2 more sources
Review effects of radiation treatment on HPV-related vulvar cancer: a meta-analysis and systematic review [PDF]
Frontiers in OncologyObjectiveVulvar carcinoma exhibits a robust correlation alongside HPV infection; however, the impact of HPV rank on the prognostic outcomes of radiation therapy within vulvar malignancies stays ambiguous.
Wei Li +7 more
doaj +2 more sources